456
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Acne Vulgaris Relapse in Sudanese Patients Treated with Oral Isotretinoin: Rate and Predictive Factors

, , & ORCID Icon
Pages 839-849 | Received 20 Jan 2023, Accepted 23 Mar 2023, Published online: 30 Mar 2023

References

  • Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754.
  • Skroza N, Tolino E, Mambrin A, et al. Adult acne versus adolescent acne: a retrospective study of 1167 patients. J Clin Aesthet Dermatol. 2018;11(1):21–25.
  • Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2018;4(2):56–71. doi:10.1016/j.ijwd.2017.10.006
  • Kurokawa I, Nakase K. Recent advances in understanding and managing acne. F1000Res. 2020;9:792. doi:10.12688/f1000research.25588.1
  • Podgórska A, Puścion-Jakubik A, Markiewicz-żukowska R, Gromkowska-Kępka KJ, Socha K. Acne vulgaris and intake of selected dietary nutrients-a summary of information. Healthcare. 2021;9(6):668. doi:10.3390/healthcare9060668
  • Oge LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Physician. 2019;100(8):475–484.
  • Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment Modalities for Acne. Molecules. 2016;21(8):1063. doi:10.3390/molecules21081063
  • Scopelliti MG, Kothare A, Karavitis M. A novel 1726-nm laser system for safe and effective treatment of acne vulgaris. Lasers Med Sci. 2022;37(9):3639–3647. doi:10.1007/s10103-022-03645-6
  • Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326(20):2055–2067. doi:10.1001/jama.2021.17633
  • Bettoli V, Guerra-Tapia A, Herane MI, Piquero-Martín J. Challenges and solutions in oral isotretinoin in acne: reflections on 35 years of experience. Clin Cosmet Investig Dermatol. 2019;12:943–951. doi:10.2147/CCID.S234231
  • Bagatin E, Costa CS, Rocha M, et al. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol. 2020;95(Suppl1):19–38.
  • Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10(12). doi:10.7573/dic.2021-8-6
  • Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2020;82(1):72–79. doi:10.1016/j.jaad.2019.06.025
  • Affleck A, Jackson D, Williams HC, Chavez P, Albrecht J. Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topic. Br J Dermatol. 2022;187(6):857–865.
  • Sevimli Dikicier B. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate. J Int Med Res. 2019;47(7):2987–2992. doi:10.1177/0300060519847367
  • Morales-Cardona CA, Sánchez-Vanegas G. Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. Actas Dermosifiliogr. 2013;104(1):61–66. doi:10.1016/j.ad.2012.05.004
  • Tran PT, Berman HS, Leavitt E, Hogeling M, Cheng CE. Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris. J Am Acad Dermatol. 2021;84(3):856–859.
  • Al-Muqarrab F, Almohssen A. Low-dose oral isotretinoin for the treatment of adult patients with mild-to-moderate acne vulgaris: systematic review and meta-analysis. Dermatol Ther. 2022;35(4):e15311. doi:10.1111/dth.15311
  • Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149(12):1392–1398. doi:10.1001/jamadermatol.2013.6746
  • Kraft J, Freiman A. Management of acne. Cmaj. 2011;183(7):E430–E435. doi:10.1503/cmaj.090374
  • Alshammari SA, Alamri Y, Alanazi AM., Almuhanna SA, Pinjabi L, Alsnaidi NA. Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin. Saudi Pharm J. 2020;28(3):374–379. doi:10.1016/j.jsps.2020.01.019
  • Dreno B, Bordet C, Seite S, Taieb C. Acne relapses: impact on quality of life and productivity. J Eur Acad Dermatol Venereol. 2019;33(5):937–943. doi:10.1111/jdv.15419
  • Kaikati J, Zoghaib S, Kechichian E, et al. The impact of acne treatment on quality of life and self-esteem: a prospective cohort study from Lebanon. Int J Womens Dermatol. 2021;7(4):415–421. doi:10.1016/j.ijwd.2021.03.005
  • Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1–S23.e1. doi:10.1016/j.jaad.2017.09.078
  • Tayel K, Attia M, Agamia N, Fadl N. Acne vulgaris: prevalence, severity, and impact on quality of life and self-esteem among Egyptian adolescents. J Egypt Public Health Assoc. 2020;95(1):30. doi:10.1186/s42506-020-00056-9
  • Heng AHS, Say Y-H, Sio YY, Ng YT, Chew FT. Epidemiological risk factors associated with acne vulgaris presentation, severity, and scarring in a Singapore Chinese population: a cross-sectional study. Dermatology. 2022;238(2):226–235. doi:10.1159/000516232
  • Heng AHS, Say YH, Sio YY, Ng YT, Chew FT. Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis. BMC Med Genomics. 2021;14(1):103. doi:10.1186/s12920-021-00953-8
  • Common JEA, Barker JN, Steensel M. What does acne genetics teach us about disease pathogenesis? Br J Dermatol. 2019;181(4):665–676. doi:10.1111/bjd.17721
  • Titus S, Hodge J. Diagnosis and treatment of acne. Am Fam Physician. 2012;86(8):734–740.
  • Demirci Saadet E. Investigation of relapse rate and factors affecting relapse after oral isotretinoin treatment in patients with acne vulgaris. Dermatol Ther. 2021;34(6):e15109. doi:10.1111/dth.15109
  • Nascimento C, Martins ALG, Milagres S, Jr I. Acne recurrence after treatment with oral isotretinoin: 5-year follow-up. Surg Cosmet Dermatol. 2011;3:188–191.
  • Skroza N, Tolino E, Balduzzi V, et al. Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data. Front Pharmacol. 2021;12:733526. doi:10.3389/fphar.2021.733526
  • Rademaker M. Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris. Int J Dermatol. 2016;55(5):518–523. doi:10.1111/ijd.12942
  • Šijak D, Horvat I, Sonicki Z, et al. Correlation between family history and the age of onset of childhood acne in relation to sex and type of acne. Acta Dermatovenerol Croat. 2019;27(2):86–89.
  • Draghici -C-C, Miulescu R-G, Petca R-C, Petca A, Dumitrașcu MC, Șandr F. Teratogenic effect of isotretinoin in both fertile females and males (Review). Exp Ther Med. 2021;21(5):534. doi:10.3892/etm.2021.9966
  • Jones M, Armstrong AW, Baldwin H, Stein Gold L, Kircik LH. ARTICLE: advances in oral isotretinoin therapy. J Drugs Dermatol. 2021;20(5):s5–s11. doi:10.36849/JDD.s072A
  • Oon HH, Wong SN, Aw DCW, Cheong WK, Goh CL, Tan HH. Acne management guidelines by the Dermatological Society of Singapore. J Clin Aesthet Dermatol. 2019;12(7):34–50.